文章摘要
申力军 辛绍杰 万志红.HO-1 在肝肾疾病中的作用研究进展[J].,2017,17(6):1172-1175
HO-1 在肝肾疾病中的作用研究进展
The Development of the Role of HO-1 in Liver and Kidney Disease
  
DOI:
中文关键词: 血红素氧合酶  肝脏疾病  肾脏疾病
英文关键词: Heme oxygenase  Liver disease  Kidney disease
基金项目:国家“十二五”科技重大专项(2012ZX10002004-005)
作者单位
申力军 辛绍杰 万志红 解放军医学院解放军302 医院肝硬化诊疗一中心解放军302 医院肝衰竭临床与研究中心 
摘要点击次数: 737
全文下载次数: 0
中文摘要:
      血红素氧合酶是血红素降解的限速酶,与酶解产物胆红素、CO 一道,共同发挥着抗氧化、抗炎、抑制细胞凋亡、改善组织微 循环等作用。血红素氧合酶1 是血红素氧合酶的诱导型,在脓毒血症、高血压、急性肺损伤等多种疾病中均呈现适应性诱导表达 并产生相应的细胞保护作用,在肝脏缺血再灌注损伤、肝硬化、肝衰竭、肝移植、急性肾损伤、移植肾损伤等疾病中也发挥着细胞 保护作用。本文综述了近年来血红素氧合酶1 在肝肾疾病中作用的研究进展,以期为未来治疗方法带来新突破。
英文摘要:
      The heme oxygenase, as a rate limiting enzyme in the process of heme degradation, plays an important role in antioxidant, anti-inflammatory, inhibiting cell apoptosis and improving tissue microcirculation together with the hydrolysates of bilirubin, CO. Heme oxygenase 1, an inducible heme oxygenase, can be adaptively induced and cytoprotective in septicopyemia, hypertension, acute lung injury and other diseases. The cytoprotective effect of heme oxygenase 1 can also be seen in the hepatic ischemia reperfusion injury, liver cirrhosis, hepatic failure, liver transplantation, acute kidney injury as well as renal allograft injury. The recent development of the role of heme oxygenase 1 in liver and kidney disease is reviewed in order to discuss the possible new breakthrough for future therapies.
查看全文   查看/发表评论  下载PDF阅读器
关闭